Salud financiera de hoja de balance de Zentek

Salud financiera controles de criterios 3/6

Zentek tiene un patrimonio de los accionistas total de CA$22.5M y una deuda total de CA$757.7K, lo que sitúa su ratio deuda-patrimonio en 3.4%. Sus activos y pasivos totales son CA$24.8M y CA$2.4M respectivamente.

Información clave

3.4%

Ratio deuda-patrimonio

CA$757.73k

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	CA$5.35m
Patrimonio	CA$22.47m
Total pasivo	CA$2.36m
Activos totales	CA$24.83m

Actualizaciones recientes sobre salud financiera

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26

Recent updates

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CA$9.7M) de ZEN superan a sus pasivos a corto plazo (CA$1.6M).

Pasivo a largo plazo: Los activos a corto plazo de ZEN (CA$9.7M) superan a sus pasivos a largo plazo (CA$759.6K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: ZEN tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de ZEN ha crecido de 0% a 3.4% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: ZEN tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: ZEN tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 39.2% cada año

Salud financiera de hoja de balance de Zentek

Salud financiera controles de criterios 3/6

Información clave

Actualizaciones recientes sobre salud financiera

Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Recent updates

Zentek Ltd. Announces Board and Management Changes

Zentek Ltd. Provides ZenGUARD Business Update

New major risk - Financial position

Zentek Ltd.'s Subsidiary Triera Biosciences Ltd. Completes Testing of Its C19HBA Aptamer as Potential Therapeutic

Zentek Ltd. Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

Zentek Ltd. Announces Board Changes

Zentek Ltd. Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

Zentek Ltd. announced a financing transaction

Chief Science Officer exercised options to buy CA$61k worth of stock.

Zentek Ltd. Completes Return on Investment Analysis for Canadian Healthcare System

Zentek Ltd. Elects John Snisarenko as Director

Zentek Ltd Announces the Successful Results of A Recent Study Conducted by ParticleOne

Zentek Ltd. Announces the Results of Study Comparing the Viral Filtration Efficiency of Its Zenguard-Enhanced MERV 9 Filters with an Uncoated MERV 9 Filter

CEO & Director exercised options to buy CA$275k worth of stock.

First quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.051 loss in 1Q 2023)

Zentek Ltd., Annual General Meeting, Oct 05, 2023

Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential

Zentek Ltd. Announces Updates to Senior Management Team

COO & Director exercised options to buy CA$634k worth of stock.

Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC

Full year 2023 earnings released: CA$0.14 loss per share (vs CA$0.13 loss in FY 2022)

Zentek Ltd. Appoints Lisa Sim to the Board of Directors

Albany Graphite Corp. acquired Albany Graphite Project from Zentek Ltd. for approximately CAD 136 million.

Zentek Ltd. Introduces A Novel Corrosion Protection Technology: ZenARMOR

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Announces Appointment of Mitch Swergold as Director of Investor Relations

Zentek Ltd Announces Successful Phase 2 Results of HVAC Testing

Less than half of directors are independent

Zentek Ltd. Provides Update on Battery Technology Development

Zentek Provides Update on Icephobic Coating Technology

Zentek Ltd. Provides Update on HVAC Testing

Zentek Ltd., Annual General Meeting, Sep 29, 2022

Zentek Files Provisional Patent on the Use of ZenGUARD as an Anti-Inflammatory Agent

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Zentek Ltd. Appoints Ilse Treurnicht to Its Board of Directors

Zentek Ltd. Provides Update on ZenGUARDTM Patent Status

Zentek Ltd. Announces Chief Financial Officer Changes

Less than half of directors are independent

Zentek Ltd. Announces Start of Phase Two Testing of Zenguardtm -Coated Filters

Zentek Ltd. Announces Filing of Provisional Patent for Fire-Retardant Additive

Zentek Ltd. Appoints Ravi Kaza to Its Advisory Board

Zentek Ltd. Announces Development of Graphene-Wrapped Silicon Anodes

Zentek Ltd. announced that it has received CAD 10.009022 million in funding

Zentek Ltd. announced that it expects to receive CAD 10.009022 million in funding

CEO & Director recently bought CA$149k worth of stock

Zen Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuardTM Mask

CEO & Director exercised options to buy CA$1.7m worth of stock.

President exercised options and sold CA$106k worth of stock

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

CEO & Director recently bought CA$146k worth of stock

ZEN Graphene Solutions Ltd. Develops Stable Diesel Fuel Additive

ZEN Graphene Solutions Ltd. announced that it has received CAD 4.337998 million in funding

ZEN Graphene Solutions Ltd. announced that it expects to receive CAD 2 million in funding

ZEN Graphene Solutions Ltd. Announces Successful Testing of its Graphene Compound Against Antimicrobial-Resistant Bacteria

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

ZEN Graphene Solutions and Trebor Rx Corp. Announce Successful Health Canada Testing Requirements of Surgical Masks

Zen Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound

ZEN Graphene Solutions Ltd. Announces Management Changes

New 90-day high: CA$3.75

Zen Graphene Solutions Ltd. Provides Update on Cytotoxicity Testing of Graphene-Based Compound and Effectiveness of Graphene-Based Coating

New 90-day high: CA$1.98

Vice President of Operations recently sold CA$167k worth of stock

Independent Director recently bought CA$58k worth of stock

ZEN Graphene Solutions Ltd. Appoints Gregory Fenton as New Chief Executive Officer

Independent Director recently bought CA$58k worth of stock

COO & Project Manager exercised options to buy CA$150k worth of stock.

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Chief Strategy Officer & Director exercised options to buy CA$268k worth of stock.

New 90-day high: CA$1.23